BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6177881)

  • 1. [Biochemical markers in the neoplasms of the liver, biliary tract and pancreas].
    Higashino K; Sumikawa K
    Nihon Rinsho; 1982; 40(1):43-50. PubMed ID: 6177881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological markers in the detection of neoplasms of the liver, biliary tract and pancreas].
    Matsuno S; Kobari M; Kodera T; Sato T
    Nihon Rinsho; 1982; 40(1):51-7. PubMed ID: 6177882
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodiagnosis of gastrointestinal tract cancer.
    Lehmann FG
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):176-83. PubMed ID: 88861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma].
    Iwamoto I; Furukawa M; Ito S; Nakata T; Tanigawa M; Koga Y; Magari Y
    Gan No Rinsho; 1988 Feb; 34(2):208-12. PubMed ID: 2450213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a hepatoma-liver antigen in the sera of patients with primary hepatocellular carcinoma.
    Oon CJ; Yo Sui Lan
    Singapore Med J; 1979 Jun; 20(2):317-22. PubMed ID: 92056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO
    Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Useful blood tests in the diagnosis and management of cancer: a review. Part III Antigens and Antibodies.
    Hartman HA; Foley JF
    Nebr Med J; 1977 Jun; 62(6):184-9. PubMed ID: 69997
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 13. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
    Barroso A; Alpert E
    Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of a pancreatic oncofetal antigen (POA) in carcinoma of the pancreas].
    Hishinuma S; Takami H; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Miyoshi K; Ishii T; Yamamori S
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1432-7. PubMed ID: 6097615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carcino-fetal antigens in gastroenterology].
    Chevrel B
    Presse Med (1893); 1971 Aug 28-Sep 4; 79(36):1579. PubMed ID: 4143477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carcinoembryonic antigens].
    Burtin P
    Pathol Biol (Paris); 1980 Oct; 28(8):489-92. PubMed ID: 6159563
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinofetal antigens (author's transl)].
    Hirai H
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):579-93. PubMed ID: 80809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of carcinoembryonic antigen and alpha fetoproteins in primary and secondary liver carcinoma].
    Glisić Lj; Perisić V; Lemberger J; Pastrakuljić N; Novaković R
    Srp Arh Celok Lek; 1979 Feb; 107(2):117-23. PubMed ID: 93784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.